ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Preclinical Assets Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-32L12237
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Preclinical Assets Market Research Report 2022
BUY CHAPTERS

Global Preclinical Assets Market Research Report 2025

Code: QYRE-Auto-32L12237
Report
March 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Eurofins Scientific
SGS Ltd
Intertek Group
IQVIA
ICON
Medpace
PPD
Crown Bioscience
TCG Lifesciences
DomaineX
Absorption Systems
Viroclinics Xplore
AmplifyBio
Comparative Biosciences
Pharmatest Services

Preclinical Assets Market

The global market for Preclinical Assets was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Preclinical Assets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Preclinical Assets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Preclinical Assets in Biopharmaceutical Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Preclinical Assets include Eurofins Scientific, Viroclinics Xplore, SGS, Intertek Group, AmplifyBio, IQVIA, ICON plc, Medpace, Pharmatest Services, PPD, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Preclinical Assets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preclinical Assets.
The Preclinical Assets market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Preclinical Assets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Preclinical Assets companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Preclinical Assets Market Report

Report Metric Details
Report Name Preclinical Assets Market
Segment by Type
Segment by Application
  • Biopharmaceutical Companies
  • Government Institutes
  • Research institutes
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Eurofins Scientific, Viroclinics Xplore, SGS, Intertek Group, AmplifyBio, IQVIA, ICON plc, Medpace, Pharmatest Services, PPD, Crown Bioscience, Comparative Biosciences, TCG Lifesciences, Domainex, Absorption Systems
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Preclinical Assets company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Preclinical Assets Market report?

Ans: The main players in the Preclinical Assets Market are Eurofins Scientific, Viroclinics Xplore, SGS, Intertek Group, AmplifyBio, IQVIA, ICON plc, Medpace, Pharmatest Services, PPD, Crown Bioscience, Comparative Biosciences, TCG Lifesciences, Domainex, Absorption Systems

What are the Application segmentation covered in the Preclinical Assets Market report?

Ans: The Applications covered in the Preclinical Assets Market report are Biopharmaceutical Companies, Government Institutes, Research institutes, Others

What are the Type segmentation covered in the Preclinical Assets Market report?

Ans: The Types covered in the Preclinical Assets Market report are Bioanalysis and DMPK Studies, Toxicology Testing, Compound Management, Safety Pharmacology, Others

Recommended Reports

Biopharmaceutical Industry

Cancer & Therapeutics

Preclinical & Clinical Services

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preclinical Assets Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Bioanalysis and DMPK Studies
1.2.3 Toxicology Testing
1.2.4 Compound Management
1.2.5 Safety Pharmacology
1.2.6 Others
1.3 Market by Application
1.3.1 Global Preclinical Assets Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biopharmaceutical Companies
1.3.3 Government Institutes
1.3.4 Research institutes
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Preclinical Assets Market Perspective (2020-2031)
2.2 Global Preclinical Assets Growth Trends by Region
2.2.1 Global Preclinical Assets Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Preclinical Assets Historic Market Size by Region (2020-2025)
2.2.3 Preclinical Assets Forecasted Market Size by Region (2026-2031)
2.3 Preclinical Assets Market Dynamics
2.3.1 Preclinical Assets Industry Trends
2.3.2 Preclinical Assets Market Drivers
2.3.3 Preclinical Assets Market Challenges
2.3.4 Preclinical Assets Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Preclinical Assets Players by Revenue
3.1.1 Global Top Preclinical Assets Players by Revenue (2020-2025)
3.1.2 Global Preclinical Assets Revenue Market Share by Players (2020-2025)
3.2 Global Preclinical Assets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Preclinical Assets Revenue
3.4 Global Preclinical Assets Market Concentration Ratio
3.4.1 Global Preclinical Assets Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preclinical Assets Revenue in 2024
3.5 Global Key Players of Preclinical Assets Head office and Area Served
3.6 Global Key Players of Preclinical Assets, Product and Application
3.7 Global Key Players of Preclinical Assets, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Preclinical Assets Breakdown Data by Type
4.1 Global Preclinical Assets Historic Market Size by Type (2020-2025)
4.2 Global Preclinical Assets Forecasted Market Size by Type (2026-2031)
5 Preclinical Assets Breakdown Data by Application
5.1 Global Preclinical Assets Historic Market Size by Application (2020-2025)
5.2 Global Preclinical Assets Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Preclinical Assets Market Size (2020-2031)
6.2 North America Preclinical Assets Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Preclinical Assets Market Size by Country (2020-2025)
6.4 North America Preclinical Assets Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Preclinical Assets Market Size (2020-2031)
7.2 Europe Preclinical Assets Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Preclinical Assets Market Size by Country (2020-2025)
7.4 Europe Preclinical Assets Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Preclinical Assets Market Size (2020-2031)
8.2 Asia-Pacific Preclinical Assets Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Preclinical Assets Market Size by Region (2020-2025)
8.4 Asia-Pacific Preclinical Assets Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Preclinical Assets Market Size (2020-2031)
9.2 Latin America Preclinical Assets Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Preclinical Assets Market Size by Country (2020-2025)
9.4 Latin America Preclinical Assets Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Preclinical Assets Market Size (2020-2031)
10.2 Middle East & Africa Preclinical Assets Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Preclinical Assets Market Size by Country (2020-2025)
10.4 Middle East & Africa Preclinical Assets Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurofins Scientific
11.1.1 Eurofins Scientific Company Details
11.1.2 Eurofins Scientific Business Overview
11.1.3 Eurofins Scientific Preclinical Assets Introduction
11.1.4 Eurofins Scientific Revenue in Preclinical Assets Business (2020-2025)
11.1.5 Eurofins Scientific Recent Development
11.2 Viroclinics Xplore
11.2.1 Viroclinics Xplore Company Details
11.2.2 Viroclinics Xplore Business Overview
11.2.3 Viroclinics Xplore Preclinical Assets Introduction
11.2.4 Viroclinics Xplore Revenue in Preclinical Assets Business (2020-2025)
11.2.5 Viroclinics Xplore Recent Development
11.3 SGS
11.3.1 SGS Company Details
11.3.2 SGS Business Overview
11.3.3 SGS Preclinical Assets Introduction
11.3.4 SGS Revenue in Preclinical Assets Business (2020-2025)
11.3.5 SGS Recent Development
11.4 Intertek Group
11.4.1 Intertek Group Company Details
11.4.2 Intertek Group Business Overview
11.4.3 Intertek Group Preclinical Assets Introduction
11.4.4 Intertek Group Revenue in Preclinical Assets Business (2020-2025)
11.4.5 Intertek Group Recent Development
11.5 AmplifyBio
11.5.1 AmplifyBio Company Details
11.5.2 AmplifyBio Business Overview
11.5.3 AmplifyBio Preclinical Assets Introduction
11.5.4 AmplifyBio Revenue in Preclinical Assets Business (2020-2025)
11.5.5 AmplifyBio Recent Development
11.6 IQVIA
11.6.1 IQVIA Company Details
11.6.2 IQVIA Business Overview
11.6.3 IQVIA Preclinical Assets Introduction
11.6.4 IQVIA Revenue in Preclinical Assets Business (2020-2025)
11.6.5 IQVIA Recent Development
11.7 ICON plc
11.7.1 ICON plc Company Details
11.7.2 ICON plc Business Overview
11.7.3 ICON plc Preclinical Assets Introduction
11.7.4 ICON plc Revenue in Preclinical Assets Business (2020-2025)
11.7.5 ICON plc Recent Development
11.8 Medpace
11.8.1 Medpace Company Details
11.8.2 Medpace Business Overview
11.8.3 Medpace Preclinical Assets Introduction
11.8.4 Medpace Revenue in Preclinical Assets Business (2020-2025)
11.8.5 Medpace Recent Development
11.9 Pharmatest Services
11.9.1 Pharmatest Services Company Details
11.9.2 Pharmatest Services Business Overview
11.9.3 Pharmatest Services Preclinical Assets Introduction
11.9.4 Pharmatest Services Revenue in Preclinical Assets Business (2020-2025)
11.9.5 Pharmatest Services Recent Development
11.10 PPD
11.10.1 PPD Company Details
11.10.2 PPD Business Overview
11.10.3 PPD Preclinical Assets Introduction
11.10.4 PPD Revenue in Preclinical Assets Business (2020-2025)
11.10.5 PPD Recent Development
11.11 Crown Bioscience
11.11.1 Crown Bioscience Company Details
11.11.2 Crown Bioscience Business Overview
11.11.3 Crown Bioscience Preclinical Assets Introduction
11.11.4 Crown Bioscience Revenue in Preclinical Assets Business (2020-2025)
11.11.5 Crown Bioscience Recent Development
11.12 Comparative Biosciences
11.12.1 Comparative Biosciences Company Details
11.12.2 Comparative Biosciences Business Overview
11.12.3 Comparative Biosciences Preclinical Assets Introduction
11.12.4 Comparative Biosciences Revenue in Preclinical Assets Business (2020-2025)
11.12.5 Comparative Biosciences Recent Development
11.13 TCG Lifesciences
11.13.1 TCG Lifesciences Company Details
11.13.2 TCG Lifesciences Business Overview
11.13.3 TCG Lifesciences Preclinical Assets Introduction
11.13.4 TCG Lifesciences Revenue in Preclinical Assets Business (2020-2025)
11.13.5 TCG Lifesciences Recent Development
11.14 Domainex
11.14.1 Domainex Company Details
11.14.2 Domainex Business Overview
11.14.3 Domainex Preclinical Assets Introduction
11.14.4 Domainex Revenue in Preclinical Assets Business (2020-2025)
11.14.5 Domainex Recent Development
11.15 Absorption Systems
11.15.1 Absorption Systems Company Details
11.15.2 Absorption Systems Business Overview
11.15.3 Absorption Systems Preclinical Assets Introduction
11.15.4 Absorption Systems Revenue in Preclinical Assets Business (2020-2025)
11.15.5 Absorption Systems Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Eurofins Scientific
SGS Ltd
Intertek Group
IQVIA
ICON
Medpace
PPD
Crown Bioscience
TCG Lifesciences
DomaineX
Absorption Systems
Viroclinics Xplore
AmplifyBio
Comparative Biosciences
Pharmatest Services
List of Tables
 Table 1. Global Preclinical Assets Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Bioanalysis and DMPK Studies
 Table 3. Key Players of Toxicology Testing
 Table 4. Key Players of Compound Management
 Table 5. Key Players of Safety Pharmacology
 Table 6. Key Players of Others
 Table 7. Global Preclinical Assets Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Preclinical Assets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Preclinical Assets Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Preclinical Assets Market Share by Region (2020-2025)
 Table 11. Global Preclinical Assets Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Preclinical Assets Market Share by Region (2026-2031)
 Table 13. Preclinical Assets Market Trends
 Table 14. Preclinical Assets Market Drivers
 Table 15. Preclinical Assets Market Challenges
 Table 16. Preclinical Assets Market Restraints
 Table 17. Global Preclinical Assets Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Preclinical Assets Market Share by Players (2020-2025)
 Table 19. Global Top Preclinical Assets Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preclinical Assets as of 2024)
 Table 20. Ranking of Global Top Preclinical Assets Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Preclinical Assets Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Preclinical Assets, Headquarters and Area Served
 Table 23. Global Key Players of Preclinical Assets, Product and Application
 Table 24. Global Key Players of Preclinical Assets, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Preclinical Assets Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Preclinical Assets Revenue Market Share by Type (2020-2025)
 Table 28. Global Preclinical Assets Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Preclinical Assets Revenue Market Share by Type (2026-2031)
 Table 30. Global Preclinical Assets Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Preclinical Assets Revenue Market Share by Application (2020-2025)
 Table 32. Global Preclinical Assets Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Preclinical Assets Revenue Market Share by Application (2026-2031)
 Table 34. North America Preclinical Assets Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Preclinical Assets Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Preclinical Assets Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Preclinical Assets Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Preclinical Assets Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Preclinical Assets Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Preclinical Assets Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Preclinical Assets Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Preclinical Assets Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Preclinical Assets Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Preclinical Assets Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Preclinical Assets Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Preclinical Assets Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Preclinical Assets Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Preclinical Assets Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Eurofins Scientific Company Details
 Table 50. Eurofins Scientific Business Overview
 Table 51. Eurofins Scientific Preclinical Assets Product
 Table 52. Eurofins Scientific Revenue in Preclinical Assets Business (2020-2025) & (US$ Million)
 Table 53. Eurofins Scientific Recent Development
 Table 54. Viroclinics Xplore Company Details
 Table 55. Viroclinics Xplore Business Overview
 Table 56. Viroclinics Xplore Preclinical Assets Product
 Table 57. Viroclinics Xplore Revenue in Preclinical Assets Business (2020-2025) & (US$ Million)
 Table 58. Viroclinics Xplore Recent Development
 Table 59. SGS Company Details
 Table 60. SGS Business Overview
 Table 61. SGS Preclinical Assets Product
 Table 62. SGS Revenue in Preclinical Assets Business (2020-2025) & (US$ Million)
 Table 63. SGS Recent Development
 Table 64. Intertek Group Company Details
 Table 65. Intertek Group Business Overview
 Table 66. Intertek Group Preclinical Assets Product
 Table 67. Intertek Group Revenue in Preclinical Assets Business (2020-2025) & (US$ Million)
 Table 68. Intertek Group Recent Development
 Table 69. AmplifyBio Company Details
 Table 70. AmplifyBio Business Overview
 Table 71. AmplifyBio Preclinical Assets Product
 Table 72. AmplifyBio Revenue in Preclinical Assets Business (2020-2025) & (US$ Million)
 Table 73. AmplifyBio Recent Development
 Table 74. IQVIA Company Details
 Table 75. IQVIA Business Overview
 Table 76. IQVIA Preclinical Assets Product
 Table 77. IQVIA Revenue in Preclinical Assets Business (2020-2025) & (US$ Million)
 Table 78. IQVIA Recent Development
 Table 79. ICON plc Company Details
 Table 80. ICON plc Business Overview
 Table 81. ICON plc Preclinical Assets Product
 Table 82. ICON plc Revenue in Preclinical Assets Business (2020-2025) & (US$ Million)
 Table 83. ICON plc Recent Development
 Table 84. Medpace Company Details
 Table 85. Medpace Business Overview
 Table 86. Medpace Preclinical Assets Product
 Table 87. Medpace Revenue in Preclinical Assets Business (2020-2025) & (US$ Million)
 Table 88. Medpace Recent Development
 Table 89. Pharmatest Services Company Details
 Table 90. Pharmatest Services Business Overview
 Table 91. Pharmatest Services Preclinical Assets Product
 Table 92. Pharmatest Services Revenue in Preclinical Assets Business (2020-2025) & (US$ Million)
 Table 93. Pharmatest Services Recent Development
 Table 94. PPD Company Details
 Table 95. PPD Business Overview
 Table 96. PPD Preclinical Assets Product
 Table 97. PPD Revenue in Preclinical Assets Business (2020-2025) & (US$ Million)
 Table 98. PPD Recent Development
 Table 99. Crown Bioscience Company Details
 Table 100. Crown Bioscience Business Overview
 Table 101. Crown Bioscience Preclinical Assets Product
 Table 102. Crown Bioscience Revenue in Preclinical Assets Business (2020-2025) & (US$ Million)
 Table 103. Crown Bioscience Recent Development
 Table 104. Comparative Biosciences Company Details
 Table 105. Comparative Biosciences Business Overview
 Table 106. Comparative Biosciences Preclinical Assets Product
 Table 107. Comparative Biosciences Revenue in Preclinical Assets Business (2020-2025) & (US$ Million)
 Table 108. Comparative Biosciences Recent Development
 Table 109. TCG Lifesciences Company Details
 Table 110. TCG Lifesciences Business Overview
 Table 111. TCG Lifesciences Preclinical Assets Product
 Table 112. TCG Lifesciences Revenue in Preclinical Assets Business (2020-2025) & (US$ Million)
 Table 113. TCG Lifesciences Recent Development
 Table 114. Domainex Company Details
 Table 115. Domainex Business Overview
 Table 116. Domainex Preclinical Assets Product
 Table 117. Domainex Revenue in Preclinical Assets Business (2020-2025) & (US$ Million)
 Table 118. Domainex Recent Development
 Table 119. Absorption Systems Company Details
 Table 120. Absorption Systems Business Overview
 Table 121. Absorption Systems Preclinical Assets Product
 Table 122. Absorption Systems Revenue in Preclinical Assets Business (2020-2025) & (US$ Million)
 Table 123. Absorption Systems Recent Development
 Table 124. Research Programs/Design for This Report
 Table 125. Key Data Information from Secondary Sources
 Table 126. Key Data Information from Primary Sources
 Table 127. Authors List of This Report


List of Figures
 Figure 1. Preclinical Assets Picture
 Figure 2. Global Preclinical Assets Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Preclinical Assets Market Share by Type: 2024 VS 2031
 Figure 4. Bioanalysis and DMPK Studies Features
 Figure 5. Toxicology Testing Features
 Figure 6. Compound Management Features
 Figure 7. Safety Pharmacology Features
 Figure 8. Others Features
 Figure 9. Global Preclinical Assets Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Preclinical Assets Market Share by Application: 2024 VS 2031
 Figure 11. Biopharmaceutical Companies Case Studies
 Figure 12. Government Institutes Case Studies
 Figure 13. Research institutes Case Studies
 Figure 14. Others Case Studies
 Figure 15. Preclinical Assets Report Years Considered
 Figure 16. Global Preclinical Assets Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 17. Global Preclinical Assets Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Preclinical Assets Market Share by Region: 2024 VS 2031
 Figure 19. Global Preclinical Assets Market Share by Players in 2024
 Figure 20. Global Top Preclinical Assets Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preclinical Assets as of 2024)
 Figure 21. The Top 10 and 5 Players Market Share by Preclinical Assets Revenue in 2024
 Figure 22. North America Preclinical Assets Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. North America Preclinical Assets Market Share by Country (2020-2031)
 Figure 24. United States Preclinical Assets Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Canada Preclinical Assets Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Preclinical Assets Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Preclinical Assets Market Share by Country (2020-2031)
 Figure 28. Germany Preclinical Assets Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. France Preclinical Assets Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. U.K. Preclinical Assets Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Italy Preclinical Assets Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Russia Preclinical Assets Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Nordic Countries Preclinical Assets Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Preclinical Assets Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Preclinical Assets Market Share by Region (2020-2031)
 Figure 36. China Preclinical Assets Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Japan Preclinical Assets Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. South Korea Preclinical Assets Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Preclinical Assets Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. India Preclinical Assets Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Australia Preclinical Assets Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Preclinical Assets Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Preclinical Assets Market Share by Country (2020-2031)
 Figure 44. Mexico Preclinical Assets Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Brazil Preclinical Assets Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Preclinical Assets Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Preclinical Assets Market Share by Country (2020-2031)
 Figure 48. Turkey Preclinical Assets Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Preclinical Assets Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. UAE Preclinical Assets Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Eurofins Scientific Revenue Growth Rate in Preclinical Assets Business (2020-2025)
 Figure 52. Viroclinics Xplore Revenue Growth Rate in Preclinical Assets Business (2020-2025)
 Figure 53. SGS Revenue Growth Rate in Preclinical Assets Business (2020-2025)
 Figure 54. Intertek Group Revenue Growth Rate in Preclinical Assets Business (2020-2025)
 Figure 55. AmplifyBio Revenue Growth Rate in Preclinical Assets Business (2020-2025)
 Figure 56. IQVIA Revenue Growth Rate in Preclinical Assets Business (2020-2025)
 Figure 57. ICON plc Revenue Growth Rate in Preclinical Assets Business (2020-2025)
 Figure 58. Medpace Revenue Growth Rate in Preclinical Assets Business (2020-2025)
 Figure 59. Pharmatest Services Revenue Growth Rate in Preclinical Assets Business (2020-2025)
 Figure 60. PPD Revenue Growth Rate in Preclinical Assets Business (2020-2025)
 Figure 61. Crown Bioscience Revenue Growth Rate in Preclinical Assets Business (2020-2025)
 Figure 62. Comparative Biosciences Revenue Growth Rate in Preclinical Assets Business (2020-2025)
 Figure 63. TCG Lifesciences Revenue Growth Rate in Preclinical Assets Business (2020-2025)
 Figure 64. Domainex Revenue Growth Rate in Preclinical Assets Business (2020-2025)
 Figure 65. Absorption Systems Revenue Growth Rate in Preclinical Assets Business (2020-2025)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Preclinical Testing Service Market Research Report 2025
Global Pre Clinical Testing Service Market Research Report 2025
Global Preclinical CRO Services Market Research Report 2024
Preclinical Medical Device Testing Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Preclinical Drug Development Services Market Research Report 2025
Global Clinical Stage Biotechnology Market Research Report 2025
Pre Clinical Contract Research Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Preclinical CRO Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ready to Use Antibodies Market Research Report 2025
Global Assets Under Management Market Research Report 2024
Global BCC Drug Market Research Report 2024
Global Preclinical Imaging In VIVO Market Research Report 2024
Global Preclinical MRI Equipment Market Research Report 2024
Global Biological Assets Valuation Market Research Report 2024
Drug Discovery and Preclinical CRO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global In Vivo Preclinical Brain Imaging Devices Market Research Report 2024
Global HIV Clinical Trials Market Research Report 2025
Laboratory Infrastructure Market
Global Pharmaceutical Asset Management Market Research Report 2025
Global International Clinical CRO Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions